VWUAX yields 10.77% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 8
Combined, VWUAX + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VWUAX + MRK for your $10,000?
Vanguard’s oldest growth fund focuses on well-known blue-chip companies that tend to hold strong positions in their respective industries. The fund’s investment advisors believe these companies have the ability to deliver positive earnings growth and superior returns over the long term. The fund is typically invested in a portfolio of primarily large-capitalization stocks. Investors with a long-term investment horizon who want exposure to large growth companies may wish to consider this fund.The Vanguard U.S. Growth Fund is a standalone product and is separate and distinct from the Vanguard Wellington U.S. Growth Active ETF (VUSG). Differences in each fund’s investment approach and management team are expected to result in different investment returns.
Full VWUAX Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.